Alnylam stock drops on rival heart trial: Why analysts see core business safe
Go back to Alnylam stock drops on rival heart trial: Why analysts see core business safe| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 260.10 -6.01 (2.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $266.11 | 52 Week High | $109.10 | |||
| Open | $259.00 | 52 Week Low | $31.38 | |||
| Day High | $272.08 | P/E | N/A | |||
| Day Low | $254.01 | EPS | $-1.45 | |||
| Volume | 1,997,435 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 5,144,714 | |||||
| (NASDAQ: IONS) | Delayed: 56.71 -1.38 (2.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.09 | 52 Week High | $62.68 | |||
| Open | $52.15 | 52 Week Low | $19.59 | |||
| Day High | $57.43 | P/E | N/A | |||
| Day Low | $52.15 | EPS | $0.00 | |||
| Volume | 9,097,736 | |||||
